Remove 2020 Remove Artificial Inteligence Remove Blogging Remove San Diego
article thumbnail

Flagship Adds $1.1B for New Meds, More AI, & “Health Security”

Xconomy

Flagship Pioneering founder and CEO Noubar Afeyan didn’t know a global pandemic was in the cards for 2020 when he and his team laid out three new thematic areas of focus for the company last fall.

article thumbnail

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem?s Approval & More

Xconomy

ASCO 2020 won’t be the Windy City gathering it usually is, but drug and diagnostics developers are still raring to share fresh data from their efforts in cancer immunotherapy, targeted treatments, and early-stage screening methods during the course of the three-day scientific program.